Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex for Preventing Recurrent Vitreous Hemorrhage in PDRP
NCT01478737Phase 2Completed
- Start
- Nov 2011
- Primary completion
- Apr 2016
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ozurdex in proliferative diabetic retinopathy (PDR). Started Nov 2011; status: completed.
02
Drugs
ozurdex
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01478737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478737.